Overview: Beta Thalassemia Mutation TestIntroduction: The Beta Thalassemia Mutation Test detects beta thalassemia mutations to diagnose anemia, causing weakness or jaundice. Following 2023 ASH guidelines, it uses PCR for high specificity, supporting blood disorder screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in molecular pathology for patients with suspected beta thalassemia.
Other Names: Beta Thalassemia PCR Assay, HBB Mutation Test.
FDA Status: Laboratory-developed test (LDT), meeting molecular pathology standards for diagnostic accuracy.
Historical Milestone: Beta thalassemia testing began in the 1980s with genetic research. PCR methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Detects beta thalassemia mutations to diagnose anemia, guides treatment, and evaluates patients with weakness or jaundice.
Test Parameters: 1. Beta Thalassemia Mutations
Pretest Condition: No fasting required. Collect whole blood, buccal swab, or saliva. Report history of weakness, jaundice, or anemia symptoms.
Specimen: Whole Blood (EDTA, 2-5 mL), Buccal Swab (sterile swab, 1-2 swabs), Saliva (sterile container, 1-2 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not frozen
Medical History: Document weakness, jaundice, or history of anemia. Include current medications, especially iron supplements.
Consent: Written consent required, detailing the tests purpose, anemia implications, and risks of sample collection.
Procedural Considerations: Uses PCR to detect beta thalassemia mutations (e.g., HBB gene variants). Results are available in 3-5 days, supporting clinical decisions. Performed in laboratories, often for anemia diagnosis.
Factors Affecting Result Accuracy: Low DNA yield or contamination can affect results. Sample quality impacts specificity.
Clinical Significance: Positive mutations confirm beta thalassemia, guiding blood transfusions or genetic counseling. Negative results may require hemoglobinopathy testing.
Specialist Consultation: Consult a hematologist for result interpretation and treatment planning.
Additional Supporting Tests: Hemoglobin electrophoresis, CBC, or genetic sequencing to confirm beta thalassemia diagnosis.
Test Limitations: Specific to beta thalassemia mutations; other anemias may be missed. Clinical correlation is needed.
References: ASH Thalassemia Guidelines, 2023; Blood, Thein SL, 2022.
